1,086
Views
11
CrossRef citations to date
0
Altmetric
Articles

Methamphetamine ‘facts’: The production of a ‘destructive’ drug in Australian scientific texts

&
Pages 451-462 | Received 21 Aug 2013, Accepted 05 Feb 2014, Published online: 18 Mar 2014

References

  • Australian Crime Commission. Australian Illicit Drug Report 1999–2000. ▪, Canberra 2001
  • American Psychiatric Association. Diagnostic statistical manual of mental disorders. American Psychiatric Association, Washington D.C. 1994
  • Carney M, (2006). The Ice Age. Four corners. Retrieved from http://www.abc.net.au/4corners/content/2006/s1593168.htm
  • Cho AK. Ice: A new dosage form of an old drug. Science 1990; 249: 631–634
  • Cho AK, Melega WP. Patterns of methamphetamine abuse and their consequences. Journal of Addictive Diseases 2001; 21: 21–34
  • Darke S, Kaye S, McKetin R, Duflou J. Major physical and psychological harms of methamphetamine use. Drug and Alcohol Review 2008; 27: 253–262
  • Degenhardt L, Roxburgh A, Black E, Bruno R, Campbell G, Kinner S, Featherston J. The epidemiology of methamphetamine use and harm in Australia. Drug and Alcohol Review 2008; 27: 243–252
  • Degenhardt L, Topp L. ‘Crystal meth’ use among polydrug users in Sydney's dance party subculture: Characteristics, use patterns and associated harms. International Journal of Drug Policy 2003; 14: 17–24
  • Dwyer R, Moore D. Enacting multiple methamphetamines: The ontological politics of public discourse and consumer accounts of a drug and its effects. International Journal of Drug Policy 2013; 24: 203–211
  • Dwyer R, Moore D. Understanding illicit drug markets in Australia. British Journal of Criminology 2010; 50: 82–101
  • Farrell M, Marsden J, Ali R, Ling W. Methamphetamine: Drug use and psychoses becomes a major public health issue in the Asia Pacific region. Addiction 2002; 97: 771–772
  • Fraser S, Moore D. Harm reduction and hepatitis C: On the ethics and politics of prevention and treatment. Addiction Research and Theory 2011a; 19: 375–379
  • Fraser S, Moore D. Governing through problems: The formulation of policy on amphetamine-type stimulants (ATS) in Australia. International Journal of Drug Policy 2011b; 22: 498–506
  • Freese TE, Obert J, Dickow A, Cohen J, Lord RH. Methamphetamine abuse: Issues for special populations. Journal of Psychoactive Drugs 2000; 32: 177–182
  • Gossop M, Darke S, Griffiths P, Hando J, Powis B, Hall W, Strang J. The Severity of Dependence Scale (SDS): Psychometric properties of the SDS in English and Australian samples of heroin, cocaine and amphetamine users. Addiction 1995; 90: 607–614
  • Greenwell L, Brecht M. Self-reported health status among treated methamphetamine users. The American Journal of Drug and Alcohol Abuse 2003; 29: 75–104
  • Hall D, Stanis J, Hector Marquez A, Gulley J. A comparison of amphetamine- and methamphetamine-induced locomotor activity in rats: Evidence for qualitative differences in behavior. Psychopharmacology 2008; 195: 469–478
  • Jasanoff S. The politics of public reason. The politics of knowledge, FD Rubio, P Baert. ▪, Abingdon: Routledge 2012; 11–32
  • Jayne M, Valentine G, Holloway SL. Emotional, embodied and affective geographies of alcohol, drinking and drunkenness. Transactions of the Institute of British Geographers 2010; 35: 540–554
  • Jenner L, Lee NK. Treatment approaches for users of methamphetamine: A practical guide for frontline workers. Australian Government Department of Health and Ageing, Canberra 2008
  • Jernigan TL, Gamst AC, Archibald SL, Fennema-Notestine C, Rivera Mindt M, Marcotte TL, Grant I, et al. Effects of methamphetamine dependence and HIV infection on cerebral morphology. The American Journal of Psychiatry 2005; 162: 1461–1472
  • Kalechstein AD, Newton TF, Green M. Methamphetamine dependence is associated with neurocognitive impairment in the initial phases of abstinence. The Journal of Neuropsychiatry and Clinical Neurosciences 2003; 15: 215–220
  • Kaye S, & McKetin, R. (2005). Cardiotoxicity associated with methamphetamine use and signs of cardiovascular pathology among methamphetamine users. NDARC Technical Report: Sydney, National Drug and Alcohol Research Centre, University of New South Wales
  • Keane H. What's wrong with addiction. Melbourne University Press, Melbourne 2002
  • Kinner SA, Degenhardt L. Crystal methamphetamine smoking among regular ecstasy users in Australia: Increases in use and associations with harm. Drug and Alcohol Review 2008; 27: 292–300
  • Kulsudjarit K. Drug problem in Southeast and Southwest Asia. Annals of the New York Academy of Sciences 2004; 1025: 446–457
  • Latour B. Has the critique run out of steam? From matter of fact to matters of concern. Critical Inquiry 2004; 30: 225–248
  • Latour B, Woolgar S. Laboratory Life: The Construction of Scientific Facts. Princeton University Press, Chichester, West Sussex 1986
  • Law J. After Method: Mess in Social Science Research. Routledge, Abingdon 2004
  • Maxwell J, Rutkowski B. The prevalence of methamphetamine and amphetamine abuse in North America: A review of the indicators, 1992–2007. Drug and Alcohol Review 2008; 27: 229–235
  • McKetin R, Kelly E, McLaren J. The relationship between crystalline methamphetamine use and dependence. Drug and Alcohol Dependence 2006; 85: 198–204
  • McKetin R, Kelly E, McLaren J, Proudfoot H. Impaired physical health among methamphetamine users in comparison with the general population: The role of methamphetamine dependence and opioid use. Drug and Alcohol Review 2008; 27: 482–489
  • McKetin R, McLaren J, Lubman D, Hides L. The prevalence of psychotic symptoms among methamphetamine users. Addiction 2006; 101: 1473–1478
  • McKetin R, McLaren J, Lubman DI, Hides L. Hostility among methamphetamine users experiencing psychotic symptoms. The American Journal on Addictions 2008; 17: 235–240
  • Messina N, Marinelli-Casey P, Hillhouse M, Rawson R, Hunter J, Ang A. Childhood adverse events and methamphetamine use among men and women. Journal of Psychoactive Drugs 2008; 40(Suppl 5)399–409
  • Ministerial Council on Drug Strategy. National Amphetamine-Type Stimulant Strategy 2008–2011. Ministerial Council on Drug Strategy, Canberra 2008
  • Mol A. Ontological politics. A word and some questions. Actor network theory and after, J Law, J Hassard. Blackwell Publishers, Oxford 1999; 74–89
  • Nordahl TE, Salo R, Leamon M. Neuropsychological effects of chronic methamphetamine use on neurotransmitters and cognition: A review. The Journal of Neuropsychiatry and Clinical Neurosciences 2003; 15: 317–325
  • Pennay A, Moore D. Exploring the micro-politics of normalisation: Narratives of pleasure, self-control and desire in a sample of young Australian ‘party drug' users. Addiction Research & Theory 2010; 18: 557–571
  • Poovey M. A history of the modern fact: Problems of knowledge in the sciences of wealth and society. University of Chicago Press, Chicago 1998
  • Rawson RA, Gonzales R, Brethen P. Treatment of methamphetamine use disorders: An update. Journal of Substance Abuse Treatment 2002; 23: 145–150
  • Rawstorne P, Digiusto E, Worth H, Zablotska I. Associations between crystal methamphetamine use and potentially unsafe sexual activity among gay men in Australia. Archives of Sexual Behavior 2007; 36: 646–654
  • Room R. Dependence and society. Addiction 1985; 80: 133–139
  • Sevak R, Stoops W, Hays L, Rush C. Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans. Journal of Pharmacology and Experimental Therapeutics 2009; 328: 1007–1018
  • Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, Dunbar GC, et al. The mini-international neuropsychiatric interview (M.I.N.I): The development and validation of a structured diagnostic interview for DSM-V and ICD-10. Journal of Clinical Psychiatry 1998; 59: 20–33
  • Shoblock JR, Sullivan EB, Maisonneuve IM, Glick SD. Neurochemical and behavioral differences between d-methamphetamine and d-amphetamine in rats. Psychopharmacology 2003; 165: 359–369
  • Suwaki H. Methamphetamine abuse in Japan. Substance Use & Misuse 1997; 32: 1817–1822
  • Topp L, Darke S. The applicability of the dependence syndrome to amphetamine. Drug and Alcohol Dependence 1997; 48: 113–118
  • Topp L, Mattick R. Choosing a cut-off on the Severity of Dependence Scale (SDS) for amphetamine users. Addiction 1997a; 92: 839–845
  • Topp L, Mattick R. Validation of the amphetamine dependence syndrome and the SamDQ. Addiction 1997b; 92: 151–162
  • Topp L, Mattick R, Lovibond P. The nature of the amphetamine dependence syndrome: Appetitive or aversive motivation?. National Drug and Alcohol Research Centre, University of New South Wales, Sydney 1995
  • Topp L, Degenhardt L, Kaye S, Darke S. The emergence of potent forms of methamphetamine in Sydney, Australia: A case study of the IDRS as a strategic early warning system. Drug and Alcohol Review 2002; 21: 341–348
  • Topp L, Kaye S, Bruno R, Longo M, Williams P, O'Reilly B, Darke S, et al. Australian Drug Trends 2001: Findings of the Illicit Drug Reporting System (IDRS). National Drug and Alcohol Research Centre, University of NewSouth Wales, Sydney 2002
  • Tsuchihashi H, Katagi M, Nishikawa M, Tatsuno M, Nishioka H, Nara A, Petty C, et al. Determination of methamphetamine and its related compounds using fourier transform raman spectroscopy. Applied Spectroscopy 1997; 51: 1796–1799
  • Tupper K. Psychoactive substances and the English language: ‘Drugs', discourses and public policy. Contemporary Drug Problems 2012; 39: 461–492
  • Wolkoff DA. Methamphetamine abuse: An overview for health care professionals. Hawaii Medical Journal 1997; 56: 34–36

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.